These include conflating the diagnostic task with the diagnostic algorithm, a superficial definition of the diagnostic task, difficulties in comparing similar algorithms, insufficient characterization of safety and performance elements, and a lack of resources to assess performance at each installed site.
While some companies (e.g. Apple, MSFT) are taking more thoughtful approaches and new legal precedents are set in the UK, an investigation by Amnesty International revealed that three companies based in France, Sweden, and the Netherlands sold facial recognition technology to key players of the Chinese mass surveillance apparatus.
Even though NVIDIA is adding sweeteners to the deal, e.g. building a £40M supercomputer for health AI research in Cambridge (UK), it appears that Chinese technology companies are pushing the state to block the deal unless access to Arm’s designs remains unhindered.
Given Arm’s hundreds of licensees who depend on its RISC technology, there is concern that its ownership by NVIDIA could jeopardize unhindered technology access (not factoring the issues of geopolitics).